Skip to main content
Equibles

UBS Group AG

Position in EXEL — Exelixis, Inc.

CIK 1610520 ZURICH, V8
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$172,364,892
+$69,707,121 QoQ
Shares Held
3,167,890
+32.4% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#19
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Derivatives in EXEL

reported options exposure · as of Jun 30, 2024
CallValue
$1,020,138
CallShares
45,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. EXEL ranks #14 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in EXEL

Export CSV
35 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $172,364,892 3,167,890
2026-03-31 $102,657,771 2,393,513
2025-12-31 $163,149,898 3,722,334
2025-09-30 $109,654,347 2,655,069
2025-06-30 $58,493,365 1,326,982
2025-03-31 $75,244,140 2,038,032
2024-12-31 $32,564,734 977,920
2024-09-30 $14,965,597 576,709
2024-06-30 $14,266,021 634,892
2024-06-30 $1,020,138 45,400
2024-03-31 $11,979,519 504,826
2023-12-31 $232,703 9,700
2023-12-31 $10,664,441 444,537
2023-12-31 $1,197,101 49,900
2023-09-30 $211,945 9,700
2023-09-30 $1,090,315 49,900
2023-09-30 $11,680,637 534,583
2023-06-30 $7,096,861 371,369
2023-06-30 $1,972,152 103,200
2023-06-30 $185,367 9,700
2023-03-31 $7,816,930 402,727
2023-03-31 $188,277 9,700
2023-03-31 $1,486,806 76,600
2022-12-31 $10,048,370 626,457
2022-09-30 $2,654,403 169,286
2022-06-30 $13,279,431 637,821
2022-03-31 $5,488,338 242,097
2021-12-31 $11,431,817 625,373
2021-09-30 $10,009,958 473,508
2021-06-30 $7,083,589 388,781
2021-03-31 $7,413,043 328,156
2020-12-31 $3,404,734 169,643
2020-09-30 $3,827,867 156,559
2020-06-30 $1,710,277 72,042
2020-03-31 $1,732,624 100,617